Steris (STE) Cash from Investing Activities (2018 - 2026)
Steris (STE) recorded quarterly Cash from Investing Activities of -$217.2 million in Q1 2026, down 120.51% quarter-over-quarter from -$98.5 million in Q4 2025, and down 211.17% on a YoY basis from $195.4 million in Q1 2025.
Steris (STE) Cash from Investing Activities (2018 - 2026) Analysis & Trends
Steris' Cash from Investing Activities history runs 9 years deep, the most recent figure standing at -$217.2 million for Q1 2026.
- In Q1 2026, Cash from Investing Activities fell 211.17% year-over-year to -$217.2 million; the TTM figure through Mar 2026 stood at -$512.5 million (down 231.82% YoY), while the FY2026 annual figure was -$512.5 million, down 231.82% from the prior year.
- Cash from Investing Activities was -$217.2 million for Q1 2026 at Steris, down from -$98.5 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $687.8 million in Q2 2024 to a low of -$606.2 million in Q3 2023.
- Historically, Cash from Investing Activities has averaged -$76.5 million across 5 years, with a median of -$98.4 million in 2022.
- The sharpest annual moves came in 2023 and 2024: Cash from Investing Activities tumbled 519.08% in 2023, then jumped 1132.79% in 2024.
- A 5-year view of Cash from Investing Activities shows it stood at -$98.4 million in 2022, then retreated by 20.84% to -$118.9 million in 2023, then dropped by 4.19% to -$123.9 million in 2024, then advanced by 20.5% to -$98.5 million in 2025, then tumbled by 120.51% to -$217.2 million in 2026.
- The last three Cash from Investing Activities figures came in at -$217.2 million (Q1 2026), -$98.5 million (Q4 2025), and -$88.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -20.32 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -185.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -816.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -591.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -92.80 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -475.32 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -298.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -2.50 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -217.20 Mn |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | -159.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -217.20 Mn |
| Mar 31, 2026 | -217.20 Mn |
| Dec 31, 2025 | -98.50 Mn |
| Dec 31, 2025 | -98.50 Mn |
| Sep 30, 2025 | -88.30 Mn |
| Sep 30, 2025 | -88.30 Mn |
| Jun 30, 2025 | -108.50 Mn |
| Jun 30, 2025 | -108.50 Mn |
| Mar 31, 2025 | -69.80 Mn |
| Mar 31, 2025 | -69.80 Mn |
| Dec 31, 2024 | -123.90 Mn |
| Dec 31, 2024 | -123.90 Mn |
| Sep 30, 2024 | -105.30 Mn |
| Sep 30, 2024 | -105.30 Mn |
| Jun 30, 2024 | 687.80 Mn |
| Jun 30, 2024 | 687.80 Mn |
| Mar 31, 2024 | -95.65 Mn |
| Mar 31, 2024 | -95.65 Mn |
| Dec 31, 2023 | -118.92 Mn |
| Dec 31, 2023 | -118.92 Mn |